Annual report pursuant to Section 13 and 15(d)

JT Pharmaceuticals Asset Purchase Agreement (Details Narrative)

v3.23.1
JT Pharmaceuticals Asset Purchase Agreement (Details Narrative) - JT Pharmaceuticals [Member] - USD ($)
$ in Thousands
1 Months Ended
Jan. 31, 2022
Oct. 31, 2020
Asset Acquisition [Line Items]    
Closing payment   $ 15,000
Milestone Payments $ 100,000  
Issuance of common stock, net (in shares) 51,021